[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Elranatamab: How it works, how it's being used, and how it compares to other bispecifics.

Elranatamab: How it works, how it's being used, and how it compares to other bispecifics. image

Elranatamab: How it works, how it's being used, and how it compares to other bispecifics.

Webinar
event Aug 20, 2024 / 06:00PM - 07:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Elranatamab is a new treatment option that we will explore with Dr. Alex Lesokhin. Come learn how it works; how it compares to other bispecifics; and who might benefit from this new treatment option.

 

Schedule & Agenda

The panelist Cynthia Cahoon, RN
6:00 PM
Introductions
Cynthia Cahoon, RN

Cynthia introduces the agenda of the event and featured speaker Dr. Alex Lesokhin

The panelist Dr. Alexander Lesokhin
6:05 PM
Presentation
Dr. Alexander Lesokhin

Dr. Alex Lesokhin talks about Elranatamab

Event panelist Audience
6:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Cynthia Cahoon, RN
Cynthia Cahoon, RN

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Read Bio
The panelist Dr. Alexander Lesokhin
Dr. Alexander Lesokhin

Alexander Lesokhin, MD, is a Hematologic Oncologist at Memorial Sloan Kettering Cancer Center (MSKCC) in New York, NY, who specializes in myeloma and immunology. His research work involves developing innovative ways to use the immune system to treat cancer. He conducts clinical studies of medicines that enhance the immune response as well as laboratory studies aimed at understanding how cancers such as multiple myeloma are able to evade the immune response with a goal of developing new ways to treat myeloma patients. Dr. Lesohkin completed his fellowship at MSKCC and his residency at New York-Presbyterian Hospital/Columbia University Medical Center. He earned his medical degree at the Albert Einstein College of Medicine in New York.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Treatments & Drugs group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.